|
Market Closed -
Toronto S.E.
04:00:00 2026-11-16 pm EST
|
5-day change | 1st Jan Change | ||
| 1.390 CAD | -5.44% |
|
-6.08% | +6.11% |
Company Valuation: Cardiol Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 142 | 43.96 | 71.77 | 151 | 130.4 | 162.4 | - | - |
| Change | - | -69.05% | 63.28% | 110.34% | -13.65% | 24.56% | - | - |
| Enterprise Value (EV) 1 | 142 | 43.96 | 36.84 | 120.4 | 108.9 | 143.3 | 155.8 | 162.4 |
| Change | - | -69.05% | -16.19% | 226.78% | -9.5% | 31.56% | 8.69% | 4.23% |
| P/E | -3.19x | -1.41x | -2.5x | -3.63x | -3.36x | -3.86x | -4.52x | -17.2x |
| PBR | - | - | 2.55x | 6.18x | 6.41x | 6.18x | 43.4x | - |
| PEG | - | 0x | 0.2x | -0.2x | 0.1x | 0.5x | 0.3x | 0.2x |
| Capitalization / Revenue | 1,803x | - | - | - | - | - | 97.4x | 3.08x |
| EV / Revenue | 1,803x | - | - | - | - | - | 93.5x | 3.08x |
| EV / EBITDA | -4.74x | -1.07x | -1.25x | -3x | -3.18x | -3.99x | -7.66x | -7.88x |
| EV / EBIT | -3.67x | -1.06x | -1.24x | -2.99x | -3.17x | -3.77x | -4.13x | -20.3x |
| EV / FCF | -6.03x | - | -1.46x | -4.8x | -4.56x | -4.6x | -4.99x | -2.51x |
| FCF Yield | -16.6% | - | -68.5% | -20.8% | -21.9% | -21.7% | -20.1% | -39.8% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.73 | -0.49 | -0.44 | -0.51 | -0.39 | -0.36 | -0.3074 | -0.081 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.0788 | - | - | - | - | - | 1.667 | 52.75 |
| EBITDA 1 | -29.95 | -41.12 | -29.54 | -40.11 | -34.21 | -35.9 | -20.34 | -20.62 |
| EBIT 1 | -38.66 | -41.34 | -29.79 | -40.28 | -34.32 | -38.05 | -37.74 | -8.013 |
| Net income 1 | -31.64 | -30.93 | -28.13 | -36.68 | -33.82 | -41.4 | -38.94 | -16.61 |
| Net Debt 1 | - | - | -34.93 | -30.58 | -21.42 | -19.05 | -6.594 | - |
| Reference price 2 | 2.330 | 0.690 | 1.100 | 1.850 | 1.310 | 1.390 | 1.390 | 1.390 |
| Nbr of stocks (in thousands) | 60,954 | 63,703 | 65,247 | 81,603 | 99,514 | 116,823 | - | - |
| Announcement Date | 3/23/22 | 3/28/23 | 4/1/24 | 3/31/25 | 3/31/26 | - | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.08x | - | -4.25x | - | 120M | ||
| 17.35x | 6.64x | 12.72x | 1.72% | 66.33B | ||
| 32.78x | 8.77x | 28.98x | 0.07% | 60.62B | ||
| 38.6x | 6.87x | 20.53x | 0.84% | 55.5B | ||
| 44.7x | 6.25x | 29.77x | -.--% | 47.58B | ||
| 34.6x | 3.29x | 14.2x | -.--% | 43.69B | ||
| -20.57x | 54.42x | -22.49x | -.--% | 37.27B | ||
| 36.15x | 8.94x | 23.31x | 0.36% | 36.57B | ||
| 40.59x | 7.91x | 26.38x | -.--% | 32.22B | ||
| -73.93x | 14x | -75.29x | -.--% | 26.58B | ||
| Average | 14.62x | 13.01x | 5.39x | 0.33% | 41B | |
| Weighted average by Cap. | 21.69x | 11.75x | 11.41x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CRDL Stock
- Valuation Cardiol Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
















